Uses of bifidobacterium longum transitional microorganism
AssigneeSociete des Produits Nestle S.A.
InventorsOLGA SAKWINSKA, STEPHANE DUBOUX, CATHERINE NGOM-BRU, NORBERT SPRENGER
Life of this patent
Estimating the term…
Abstract
The present invention relates to use of a B. longum transitional microorganism that has a preferential utilization of 3-FL over 2′FL. It also relates to methods and to a composition comprising the B. longum transitional microorganism and uses thereof.
Claims13
(canceled)
Method according to claim 9 wherein the Bidobacterium longum microorganism has an Average Nucleotide Identity (ANI) of at least 96% with at least one Bifidobacterium longum strain selected in the group consisting of CNCM I-5683, CNCM I-5684, CNCM I-5685, CNCM I-5686 and CNCM I-5687, and any combination thereof.
Method according to claim 9, wherein the Bifidobacterium longum transitional microorganism comprises a glycosyl hydrolase family 95 (GH95, α-L-galactosidase;
- α-L-fucosidase;
- α-1,2-L-fucosidase) gene having at least 60% of identity with BLON 2335 gene present in Bifidobacterium longum subsp. infantis ATCC 15697 and/or a glycosyl hydrolase family 29 (GH29, α-L-fucosidase;
- α-1,3/1,4-L-fucosidase;
- α-1,2-L-fucosidase) having at least 60% identity with BLON_2336 gene present in Bifidobacterium longum subsp. infantis ATCC 15697.
Method according to claim 9, wherein 3-fucosyllactose (3-FL) is utilized by the Bifidobacterium longum transitional microorganism over 2′-fucosyllactose (2′-FL) in a ratio between 0.1:5.
5-7. (canceled)
A method of promoting the growth of a Bidobacterium longum transitional microorganism to modulate the gut microbiota of an infant and/or of a young child, the method comprising administering to the infant and/or to the young child a composition comprising a Bifidobacterium longum transitional microorganism, wherein the Bidobacterium longum transitional microorganism is capable of utilizing prebiotic oligosaccharides and wherein the Bifidobacterium longum transitional microorganism preferentially utilizes 3-fucosyllactose (3-FL) over 2′-fucosyllactose (2′-FL).
A method of promoting/assisting the transition from a milk-based diet to solid food in an infant and/or in a young child, the method comprising administering to the infant and/or to the young child a composition comprising a Bifidobacterium longum transitional microorganism, wherein the Bifidobacterium longum transitional microorganism is capable of utilizing prebiotic oligosaccharides and wherein the Bifidobacterium longum transitional microorganism preferentially utilizes 3-fucosyllactose (3-FL) over 2′-fucosyllactose (2′-FL).
(canceled)
13-17. (canceled)
A method of promoting the growth of the Biidobacterium longum transitional microorganism that preferentially utilizes 3-fucosyllactose (3-FL) over 2′-fucosyllactose (2′-FL) to modulate the gut microbiota of an infant and/or of a young child, the method comprising administering to the infant and/or to the young child a composition comprising a Bifidobacterium longum transitional microorganism, wherein the Bifidobacterium longum transitional microorganism is capable of utilizing prebiotic oligosaccharides and wherein the Bifidobacterium longum transitional microorganism preferentially utilizes 3-fucosyllactose (3-FL) over 2′-fucosyllactose (2′-FL).
(canceled)
Dependencies are inferred from the claim text.